In the news

As America begins to open back up for business, many of us are asking why now, what’s changed? We’ve been told for weeks, even months, to stay home. So what’s different? What makes it safe now?

You must be logged in to view this item.

This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.

Stakeholders Weigh In on the Key Biosimilar Developments of 2018

The Center for Biosimilars

ASC supply chain tip of the day: Find product alternatives

Becker's ASC Review

NYC launches 1st city-led nurse residency program in the US

Becker's Clinical Leadership & Infection Control

ASC supply chain tip of the day: Measure metrics

Becker's ASC Review

Women Leaders in Supply Chain

The Journal of Healthcare Contracting

What Biosimilar Metamorphoses Are In Store For 2019?

Biosimilar Development

Observation Deck 2018

Journal of Healthcare Contracting

Doctors: If you aren't part of the opioid crisis solution, you’re part of the problem

US News and World Report

ASC supply chain tip of the day: Review data

Becker's ASC Review

Things that will cost more in 2019

Fox Business

Featured content

Why Now? What’s Changed? What Patients Think About Seeking Health Care Services During COVID